HROW FY 2013 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

FY 2013 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$10,000-90.0% YoY

Gross Profit

$10,000100.0% margin

Operating Income

-$8M-76868.8% margin

Net Income

-$8M-76431.2% margin

EPS (Diluted)

$-0.88

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$16M

Total Liabilities

$650,627

Stockholders' Equity

$15M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10,000	$100,000	-90.0%
Gross Profit	$10,000	$100,000	-90.0%
Operating Income	-$8M	-$4M	-83.9%
Net Income	-$8M	-$5M	-42.0%